Abicipar for Neovascular AMD: Two-Year Results
Risk of Adverse Ocular Events With Brolucizumab
Corneal Stiffness Metrics Signal Glaucoma Progression
Machine Learning Predicts Anti-VEGF Treatment Demand
Social Work Program Boosts Adherence to Follow-Up Care
PAK Outcomes Are Better for Contact Lens Wearers
Ethnic Disparities in Clinical Trials of Ophthalmic Drugs
Older Drivers and Accidents
PEDIG Report: Lensectomy for Traumatic Cataract
Stroke Risk Soars After RAO
Correcting Hyperopia Improves Accommodative Function